 | • レポートコード：MRC2-11QY01834 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は膵島アミロイドポリペプチドのグローバル市場について調査・分析したレポートです。種類別（AC-253、DACRA-042、DACRA-089、KBP-056、KBP-088、その他）市場規模、用途別（代謝性疾患、胃腸、筋骨格系障害、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別膵島アミロイドポリペプチドの競争状況、市場シェア ・世界の膵島アミロイドポリペプチド市場：種類別市場規模 2015年-2020年（AC-253、DACRA-042、DACRA-089、KBP-056、KBP-088、その他） ・世界の膵島アミロイドポリペプチド市場：種類別市場規模予測 2021年-2026年（AC-253、DACRA-042、DACRA-089、KBP-056、KBP-088、その他） ・世界の膵島アミロイドポリペプチド市場：用途別市場規模 2015年-2020年（代謝性疾患、胃腸、筋骨格系障害、その他） ・世界の膵島アミロイドポリペプチド市場：用途別市場規模予測 2021年-2026年（代謝性疾患、胃腸、筋骨格系障害、その他） ・北米の膵島アミロイドポリペプチド市場分析：米国、カナダ ・ヨーロッパの膵島アミロイドポリペプチド市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの膵島アミロイドポリペプチド市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の膵島アミロイドポリペプチド市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの膵島アミロイドポリペプチド市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Adocia SAS、AstraZeneca Plc、Eli Lilly and Co、Neurimmune Holding AG、Nordic Bioscience A/S、Prothena Corp Plc、reMYND NV、Zealand Pharma AS ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Islet Amyloid Polypeptide Market
The global Islet Amyloid Polypeptide market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Islet Amyloid Polypeptide Scope and Market Size
Islet Amyloid Polypeptide market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Islet Amyloid Polypeptide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Islet Amyloid Polypeptide market is segmented into
AC-253
DACRA-042
DACRA-089
KBP-056
KBP-088
Others
Segment by Application, the Islet Amyloid Polypeptide market is segmented into
Metabolic Disorders
Gastrointestinal
Musculoskeletal Disorders
Others
Regional and Country-level Analysis
The Islet Amyloid Polypeptide market is analysed and market size information is provided by regions (countries).
The key regions covered in the Islet Amyloid Polypeptide market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Islet Amyloid Polypeptide Market Share Analysis
Islet Amyloid Polypeptide market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Islet Amyloid Polypeptide business, the date to enter into the Islet Amyloid Polypeptide market, Islet Amyloid Polypeptide product introduction, recent developments, etc.
The major vendors covered:
Adocia SAS
AstraZeneca Plc
Eli Lilly and Co
Neurimmune Holding AG
Nordic Bioscience A/S
Prothena Corp Plc
reMYND NV
Zealand Pharma AS
1 Study Coverage
1.1 Islet Amyloid Polypeptide Product Introduction
1.2 Market Segments
1.3 Key Islet Amyloid Polypeptide Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Islet Amyloid Polypeptide Market Size Growth Rate by Type
1.4.2 AC-253
1.4.3 DACRA-042
1.4.4 DACRA-089
1.4.5 KBP-056
1.4.6 KBP-088
1.4.7 Others
1.5 Market by Application
1.5.1 Global Islet Amyloid Polypeptide Market Size Growth Rate by Application
1.5.2 Metabolic Disorders
1.5.3 Gastrointestinal
1.5.4 Musculoskeletal Disorders
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Islet Amyloid Polypeptide Market Size, Estimates and Forecasts
2.1.1 Global Islet Amyloid Polypeptide Revenue 2015-2026
2.1.2 Global Islet Amyloid Polypeptide Sales 2015-2026
2.2 Global Islet Amyloid Polypeptide, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Islet Amyloid Polypeptide Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Islet Amyloid Polypeptide Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Islet Amyloid Polypeptide Competitor Landscape by Players
3.1 Islet Amyloid Polypeptide Sales by Manufacturers
3.1.1 Islet Amyloid Polypeptide Sales by Manufacturers (2015-2020)
3.1.2 Islet Amyloid Polypeptide Sales Market Share by Manufacturers (2015-2020)
3.2 Islet Amyloid Polypeptide Revenue by Manufacturers
3.2.1 Islet Amyloid Polypeptide Revenue by Manufacturers (2015-2020)
3.2.2 Islet Amyloid Polypeptide Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Islet Amyloid Polypeptide Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Islet Amyloid Polypeptide Revenue in 2019
3.2.5 Global Islet Amyloid Polypeptide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Islet Amyloid Polypeptide Price by Manufacturers
3.4 Islet Amyloid Polypeptide Manufacturing Base Distribution, Product Types
3.4.1 Islet Amyloid Polypeptide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Islet Amyloid Polypeptide Product Type
3.4.3 Date of International Manufacturers Enter into Islet Amyloid Polypeptide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Islet Amyloid Polypeptide Market Size by Type (2015-2020)
4.1.1 Global Islet Amyloid Polypeptide Sales by Type (2015-2020)
4.1.2 Global Islet Amyloid Polypeptide Revenue by Type (2015-2020)
4.1.3 Islet Amyloid Polypeptide Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Islet Amyloid Polypeptide Market Size Forecast by Type (2021-2026)
4.2.1 Global Islet Amyloid Polypeptide Sales Forecast by Type (2021-2026)
4.2.2 Global Islet Amyloid Polypeptide Revenue Forecast by Type (2021-2026)
4.2.3 Islet Amyloid Polypeptide Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Islet Amyloid Polypeptide Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Islet Amyloid Polypeptide Market Size by Application (2015-2020)
5.1.1 Global Islet Amyloid Polypeptide Sales by Application (2015-2020)
5.1.2 Global Islet Amyloid Polypeptide Revenue by Application (2015-2020)
5.1.3 Islet Amyloid Polypeptide Price by Application (2015-2020)
5.2 Islet Amyloid Polypeptide Market Size Forecast by Application (2021-2026)
5.2.1 Global Islet Amyloid Polypeptide Sales Forecast by Application (2021-2026)
5.2.2 Global Islet Amyloid Polypeptide Revenue Forecast by Application (2021-2026)
5.2.3 Global Islet Amyloid Polypeptide Price Forecast by Application (2021-2026)
6 North America
6.1 North America Islet Amyloid Polypeptide by Country
6.1.1 North America Islet Amyloid Polypeptide Sales by Country
6.1.2 North America Islet Amyloid Polypeptide Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Islet Amyloid Polypeptide Market Facts & Figures by Type
6.3 North America Islet Amyloid Polypeptide Market Facts & Figures by Application
7 Europe
7.1 Europe Islet Amyloid Polypeptide by Country
7.1.1 Europe Islet Amyloid Polypeptide Sales by Country
7.1.2 Europe Islet Amyloid Polypeptide Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Islet Amyloid Polypeptide Market Facts & Figures by Type
7.3 Europe Islet Amyloid Polypeptide Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Islet Amyloid Polypeptide by Region
8.1.1 Asia Pacific Islet Amyloid Polypeptide Sales by Region
8.1.2 Asia Pacific Islet Amyloid Polypeptide Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Islet Amyloid Polypeptide Market Facts & Figures by Type
8.3 Asia Pacific Islet Amyloid Polypeptide Market Facts & Figures by Application
9 Latin America
9.1 Latin America Islet Amyloid Polypeptide by Country
9.1.1 Latin America Islet Amyloid Polypeptide Sales by Country
9.1.2 Latin America Islet Amyloid Polypeptide Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Islet Amyloid Polypeptide Market Facts & Figures by Type
9.3 Central & South America Islet Amyloid Polypeptide Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Islet Amyloid Polypeptide by Country
10.1.1 Middle East and Africa Islet Amyloid Polypeptide Sales by Country
10.1.2 Middle East and Africa Islet Amyloid Polypeptide Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Islet Amyloid Polypeptide Market Facts & Figures by Type
10.3 Middle East and Africa Islet Amyloid Polypeptide Market Facts & Figures by Application
11 Company Profiles
11.1 Adocia SAS
11.1.1 Adocia SAS Corporation Information
11.1.2 Adocia SAS Description and Business Overview
11.1.3 Adocia SAS Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Adocia SAS Islet Amyloid Polypeptide Products Offered
11.1.5 Adocia SAS Related Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Corporation Information
11.2.2 AstraZeneca Plc Description and Business Overview
11.2.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Plc Islet Amyloid Polypeptide Products Offered
11.2.5 AstraZeneca Plc Related Developments
11.3 Eli Lilly and Co
11.3.1 Eli Lilly and Co Corporation Information
11.3.2 Eli Lilly and Co Description and Business Overview
11.3.3 Eli Lilly and Co Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly and Co Islet Amyloid Polypeptide Products Offered
11.3.5 Eli Lilly and Co Related Developments
11.4 Neurimmune Holding AG
11.4.1 Neurimmune Holding AG Corporation Information
11.4.2 Neurimmune Holding AG Description and Business Overview
11.4.3 Neurimmune Holding AG Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Neurimmune Holding AG Islet Amyloid Polypeptide Products Offered
11.4.5 Neurimmune Holding AG Related Developments
11.5 Nordic Bioscience A/S
11.5.1 Nordic Bioscience A/S Corporation Information
11.5.2 Nordic Bioscience A/S Description and Business Overview
11.5.3 Nordic Bioscience A/S Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Nordic Bioscience A/S Islet Amyloid Polypeptide Products Offered
11.5.5 Nordic Bioscience A/S Related Developments
11.6 Prothena Corp Plc
11.6.1 Prothena Corp Plc Corporation Information
11.6.2 Prothena Corp Plc Description and Business Overview
11.6.3 Prothena Corp Plc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Prothena Corp Plc Islet Amyloid Polypeptide Products Offered
11.6.5 Prothena Corp Plc Related Developments
11.7 reMYND NV
11.7.1 reMYND NV Corporation Information
11.7.2 reMYND NV Description and Business Overview
11.7.3 reMYND NV Sales, Revenue and Gross Margin (2015-2020)
11.7.4 reMYND NV Islet Amyloid Polypeptide Products Offered
11.7.5 reMYND NV Related Developments
11.8 Zealand Pharma AS
11.8.1 Zealand Pharma AS Corporation Information
11.8.2 Zealand Pharma AS Description and Business Overview
11.8.3 Zealand Pharma AS Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Zealand Pharma AS Islet Amyloid Polypeptide Products Offered
11.8.5 Zealand Pharma AS Related Developments
11.1 Adocia SAS
11.1.1 Adocia SAS Corporation Information
11.1.2 Adocia SAS Description and Business Overview
11.1.3 Adocia SAS Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Adocia SAS Islet Amyloid Polypeptide Products Offered
11.1.5 Adocia SAS Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Islet Amyloid Polypeptide Market Estimates and Projections by Region
12.1.1 Global Islet Amyloid Polypeptide Sales Forecast by Regions 2021-2026
12.1.2 Global Islet Amyloid Polypeptide Revenue Forecast by Regions 2021-2026
12.2 North America Islet Amyloid Polypeptide Market Size Forecast (2021-2026)
12.2.1 North America: Islet Amyloid Polypeptide Sales Forecast (2021-2026)
12.2.2 North America: Islet Amyloid Polypeptide Revenue Forecast (2021-2026)
12.2.3 North America: Islet Amyloid Polypeptide Market Size Forecast by Country (2021-2026)
12.3 Europe Islet Amyloid Polypeptide Market Size Forecast (2021-2026)
12.3.1 Europe: Islet Amyloid Polypeptide Sales Forecast (2021-2026)
12.3.2 Europe: Islet Amyloid Polypeptide Revenue Forecast (2021-2026)
12.3.3 Europe: Islet Amyloid Polypeptide Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Islet Amyloid Polypeptide Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Islet Amyloid Polypeptide Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Islet Amyloid Polypeptide Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Islet Amyloid Polypeptide Market Size Forecast by Region (2021-2026)
12.5 Latin America Islet Amyloid Polypeptide Market Size Forecast (2021-2026)
12.5.1 Latin America: Islet Amyloid Polypeptide Sales Forecast (2021-2026)
12.5.2 Latin America: Islet Amyloid Polypeptide Revenue Forecast (2021-2026)
12.5.3 Latin America: Islet Amyloid Polypeptide Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Islet Amyloid Polypeptide Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Islet Amyloid Polypeptide Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Islet Amyloid Polypeptide Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Islet Amyloid Polypeptide Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Islet Amyloid Polypeptide Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Islet Amyloid Polypeptide Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Islet Amyloid Polypeptide Market Segments
Table 2. Ranking of Global Top Islet Amyloid Polypeptide Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Islet Amyloid Polypeptide Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AC-253
Table 5. Major Manufacturers of DACRA-042
Table 6. Major Manufacturers of DACRA-089
Table 7. Major Manufacturers of KBP-056
Table 8. Major Manufacturers of KBP-088
Table 9. Major Manufacturers of Others
Table 10. Global Islet Amyloid Polypeptide Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Islet Amyloid Polypeptide Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Islet Amyloid Polypeptide Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Islet Amyloid Polypeptide Sales Market Share by Regions (2015-2020)
Table 14. Global Islet Amyloid Polypeptide Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Islet Amyloid Polypeptide Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Islet Amyloid Polypeptide Sales Share by Manufacturers (2015-2020)
Table 17. Global Islet Amyloid Polypeptide Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Islet Amyloid Polypeptide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Islet Amyloid Polypeptide as of 2019)
Table 19. Islet Amyloid Polypeptide Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Islet Amyloid Polypeptide Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Islet Amyloid Polypeptide Price (2015-2020) (USD/Pcs)
Table 22. Islet Amyloid Polypeptide Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Islet Amyloid Polypeptide Product Type
Table 24. Date of International Manufacturers Enter into Islet Amyloid Polypeptide Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Islet Amyloid Polypeptide Sales by Type (2015-2020) (K Pcs)
Table 27. Global Islet Amyloid Polypeptide Sales Share by Type (2015-2020)
Table 28. Global Islet Amyloid Polypeptide Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Islet Amyloid Polypeptide Revenue Share by Type (2015-2020)
Table 30. Islet Amyloid Polypeptide Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Islet Amyloid Polypeptide Sales by Application (2015-2020) (K Pcs)
Table 32. Global Islet Amyloid Polypeptide Sales Share by Application (2015-2020)
Table 33. North America Islet Amyloid Polypeptide Sales by Country (2015-2020) (K Pcs)
Table 34. North America Islet Amyloid Polypeptide Sales Market Share by Country (2015-2020)
Table 35. North America Islet Amyloid Polypeptide Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Islet Amyloid Polypeptide Revenue Market Share by Country (2015-2020)
Table 37. North America Islet Amyloid Polypeptide Sales by Type (2015-2020) (K Pcs)
Table 38. North America Islet Amyloid Polypeptide Sales Market Share by Type (2015-2020)
Table 39. North America Islet Amyloid Polypeptide Sales by Application (2015-2020) (K Pcs)
Table 40. North America Islet Amyloid Polypeptide Sales Market Share by Application (2015-2020)
Table 41. Europe Islet Amyloid Polypeptide Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Islet Amyloid Polypeptide Sales Market Share by Country (2015-2020)
Table 43. Europe Islet Amyloid Polypeptide Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Islet Amyloid Polypeptide Revenue Market Share by Country (2015-2020)
Table 45. Europe Islet Amyloid Polypeptide Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Islet Amyloid Polypeptide Sales Market Share by Type (2015-2020)
Table 47. Europe Islet Amyloid Polypeptide Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Islet Amyloid Polypeptide Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Islet Amyloid Polypeptide Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Islet Amyloid Polypeptide Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Islet Amyloid Polypeptide Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Islet Amyloid Polypeptide Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Islet Amyloid Polypeptide Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Islet Amyloid Polypeptide Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Islet Amyloid Polypeptide Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Islet Amyloid Polypeptide Sales Market Share by Application (2015-2020)
Table 57. Latin America Islet Amyloid Polypeptide Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Islet Amyloid Polypeptide Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Islet Amyloid Polypeptide Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Islet Amyloid Polypeptide Revenue Market Share by Country (2015-2020)
Table 61. Latin America Islet Amyloid Polypeptide Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Islet Amyloid Polypeptide Sales Market Share by Type (2015-2020)
Table 63. Latin America Islet Amyloid Polypeptide Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Islet Amyloid Polypeptide Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Islet Amyloid Polypeptide Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Islet Amyloid Polypeptide Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Islet Amyloid Polypeptide Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Islet Amyloid Polypeptide Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Islet Amyloid Polypeptide Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Islet Amyloid Polypeptide Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Islet Amyloid Polypeptide Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Islet Amyloid Polypeptide Sales Market Share by Application (2015-2020)
Table 73. Adocia SAS Corporation Information
Table 74. Adocia SAS Description and Major Businesses
Table 75. Adocia SAS Islet Amyloid Polypeptide Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Adocia SAS Product
Table 77. Adocia SAS Recent Development
Table 78. AstraZeneca Plc Corporation Information
Table 79. AstraZeneca Plc Description and Major Businesses
Table 80. AstraZeneca Plc Islet Amyloid Polypeptide Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. AstraZeneca Plc Product
Table 82. AstraZeneca Plc Recent Development
Table 83. Eli Lilly and Co Corporation Information
Table 84. Eli Lilly and Co Description and Major Businesses
Table 85. Eli Lilly and Co Islet Amyloid Polypeptide Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Eli Lilly and Co Product
Table 87. Eli Lilly and Co Recent Development
Table 88. Neurimmune Holding AG Corporation Information
Table 89. Neurimmune Holding AG Description and Major Businesses
Table 90. Neurimmune Holding AG Islet Amyloid Polypeptide Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Neurimmune Holding AG Product
Table 92. Neurimmune Holding AG Recent Development
Table 93. Nordic Bioscience A/S Corporation Information
Table 94. Nordic Bioscience A/S Description and Major Businesses
Table 95. Nordic Bioscience A/S Islet Amyloid Polypeptide Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Nordic Bioscience A/S Product
Table 97. Nordic Bioscience A/S Recent Development
Table 98. Prothena Corp Plc Corporation Information
Table 99. Prothena Corp Plc Description and Major Businesses
Table 100. Prothena Corp Plc Islet Amyloid Polypeptide Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Prothena Corp Plc Product
Table 102. Prothena Corp Plc Recent Development
Table 103. reMYND NV Corporation Information
Table 104. reMYND NV Description and Major Businesses
Table 105. reMYND NV Islet Amyloid Polypeptide Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. reMYND NV Product
Table 107. reMYND NV Recent Development
Table 108. Zealand Pharma AS Corporation Information
Table 109. Zealand Pharma AS Description and Major Businesses
Table 110. Zealand Pharma AS Islet Amyloid Polypeptide Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Zealand Pharma AS Product
Table 112. Zealand Pharma AS Recent Development
Table 113. Global Islet Amyloid Polypeptide Sales Forecast by Regions (2021-2026) (K Pcs)
Table 114. Global Islet Amyloid Polypeptide Sales Market Share Forecast by Regions (2021-2026)
Table 115. Global Islet Amyloid Polypeptide Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 116. Global Islet Amyloid Polypeptide Revenue Market Share Forecast by Regions (2021-2026)
Table 117. North America: Islet Amyloid Polypeptide Sales Forecast by Country (2021-2026) (K Pcs)
Table 118. North America: Islet Amyloid Polypeptide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Europe: Islet Amyloid Polypeptide Sales Forecast by Country (2021-2026) (K Pcs)
Table 120. Europe: Islet Amyloid Polypeptide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Asia Pacific: Islet Amyloid Polypeptide Sales Forecast by Region (2021-2026) (K Pcs)
Table 122. Asia Pacific: Islet Amyloid Polypeptide Revenue Forecast by Region (2021-2026) (US$ Million)
Table 123. Latin America: Islet Amyloid Polypeptide Sales Forecast by Country (2021-2026) (K Pcs)
Table 124. Latin America: Islet Amyloid Polypeptide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Middle East and Africa: Islet Amyloid Polypeptide Sales Forecast by Country (2021-2026) (K Pcs)
Table 126. Middle East and Africa: Islet Amyloid Polypeptide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 128. Key Challenges
Table 129. Market Risks
Table 130. Main Points Interviewed from Key Islet Amyloid Polypeptide Players
Table 131. Islet Amyloid Polypeptide Customers List
Table 132. Islet Amyloid Polypeptide Distributors List
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Islet Amyloid Polypeptide Product Picture
Figure 2. Global Islet Amyloid Polypeptide Sales Market Share by Type in 2020 & 2026
Figure 3. AC-253 Product Picture
Figure 4. DACRA-042 Product Picture
Figure 5. DACRA-089 Product Picture
Figure 6. KBP-056 Product Picture
Figure 7. KBP-088 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Islet Amyloid Polypeptide Sales Market Share by Application in 2020 & 2026
Figure 10. Metabolic Disorders
Figure 11. Gastrointestinal
Figure 12. Musculoskeletal Disorders
Figure 13. Others
Figure 14. Islet Amyloid Polypeptide Report Years Considered
Figure 15. Global Islet Amyloid Polypeptide Market Size 2015-2026 (US$ Million)
Figure 16. Global Islet Amyloid Polypeptide Sales 2015-2026 (K Pcs)
Figure 17. Global Islet Amyloid Polypeptide Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Islet Amyloid Polypeptide Sales Market Share by Region (2015-2020)
Figure 19. Global Islet Amyloid Polypeptide Sales Market Share by Region in 2019
Figure 20. Global Islet Amyloid Polypeptide Revenue Market Share by Region (2015-2020)
Figure 21. Global Islet Amyloid Polypeptide Revenue Market Share by Region in 2019
Figure 22. Global Islet Amyloid Polypeptide Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Islet Amyloid Polypeptide Revenue in 2019
Figure 24. Islet Amyloid Polypeptide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Islet Amyloid Polypeptide Sales Market Share by Type (2015-2020)
Figure 26. Global Islet Amyloid Polypeptide Sales Market Share by Type in 2019
Figure 27. Global Islet Amyloid Polypeptide Revenue Market Share by Type (2015-2020)
Figure 28. Global Islet Amyloid Polypeptide Revenue Market Share by Type in 2019
Figure 29. Global Islet Amyloid Polypeptide Market Share by Price Range (2015-2020)
Figure 30. Global Islet Amyloid Polypeptide Sales Market Share by Application (2015-2020)
Figure 31. Global Islet Amyloid Polypeptide Sales Market Share by Application in 2019
Figure 32. Global Islet Amyloid Polypeptide Revenue Market Share by Application (2015-2020)
Figure 33. Global Islet Amyloid Polypeptide Revenue Market Share by Application in 2019
Figure 34. North America Islet Amyloid Polypeptide Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Islet Amyloid Polypeptide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Islet Amyloid Polypeptide Sales Market Share by Country in 2019
Figure 37. North America Islet Amyloid Polypeptide Revenue Market Share by Country in 2019
Figure 38. U.S. Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Islet Amyloid Polypeptide Market Share by Type in 2019
Figure 43. North America Islet Amyloid Polypeptide Market Share by Application in 2019
Figure 44. Europe Islet Amyloid Polypeptide Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Islet Amyloid Polypeptide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Islet Amyloid Polypeptide Sales Market Share by Country in 2019
Figure 47. Europe Islet Amyloid Polypeptide Revenue Market Share by Country in 2019
Figure 48. Germany Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Islet Amyloid Polypeptide Market Share by Type in 2019
Figure 59. Europe Islet Amyloid Polypeptide Market Share by Application in 2019
Figure 60. Asia Pacific Islet Amyloid Polypeptide Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Islet Amyloid Polypeptide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Islet Amyloid Polypeptide Sales Market Share by Region in 2019
Figure 63. Asia Pacific Islet Amyloid Polypeptide Revenue Market Share by Region in 2019
Figure 64. China Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Islet Amyloid Polypeptide Market Share by Type in 2019
Figure 87. Asia Pacific Islet Amyloid Polypeptide Market Share by Application in 2019
Figure 88. Latin America Islet Amyloid Polypeptide Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Islet Amyloid Polypeptide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Islet Amyloid Polypeptide Sales Market Share by Country in 2019
Figure 91. Latin America Islet Amyloid Polypeptide Revenue Market Share by Country in 2019
Figure 92. Mexico Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Islet Amyloid Polypeptide Market Share by Type in 2019
Figure 99. Latin America Islet Amyloid Polypeptide Market Share by Application in 2019
Figure 100. Middle East and Africa Islet Amyloid Polypeptide Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Islet Amyloid Polypeptide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Islet Amyloid Polypeptide Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Islet Amyloid Polypeptide Revenue Market Share by Country in 2019
Figure 104. Turkey Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Islet Amyloid Polypeptide Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Islet Amyloid Polypeptide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Islet Amyloid Polypeptide Market Share by Type in 2019
Figure 111. Middle East and Africa Islet Amyloid Polypeptide Market Share by Application in 2019
Figure 112. North America Islet Amyloid Polypeptide Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Islet Amyloid Polypeptide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Islet Amyloid Polypeptide Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Islet Amyloid Polypeptide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Islet Amyloid Polypeptide Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Islet Amyloid Polypeptide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Islet Amyloid Polypeptide Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Islet Amyloid Polypeptide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Islet Amyloid Polypeptide Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Islet Amyloid Polypeptide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
家族性アミロイド多発神経障害（FAP）の世界市場（～2026年） Familial amyloid polyneuropathy (FAP) or transthyretin (TTR) amyloid neuropathy are a rare group of autosomal dominant diseases caused by the deposition of protein and/or amyloid fibrils around the peripheral nerves and in various tissues, including the heart muscle. Globally, development of new dru…- ポリペプチド薬の世界市場（～2026年） Polypeptide antibiotic. Polypeptide antibiotics are a chemically diverse class of anti-infective and antitumor antibiotics containing non-protein polypeptide chains. Examples of this class include actinomycin, bacitracin, colistin, and polymyxin B. Actinomycin-D has found use in cancer chemotherapy.…
- 胃抑制性ポリペプチド受容体の世界市場（～2026年） Market Analysis and Insights: Global Gastric Inhibitory Polypeptide Receptor Market The global Gastric Inhibitory Polypeptide Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gastric Inhibitory Polypeptide Rece…
- ペプチド代謝障害治療薬の世界市場（～2026年） A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive. Peptide therapeutics are used to treat metabolic disorders owing to their stability, effici…
- 化学合成ポリペプチド薬の世界市場（～2026年） Chemosynthetic polypeptide drugs are composed of certain amino acids that combine to form a single unit. These drugs do produce a considerable remedial effect on different diseases, however, accompanied by a few side effects. Chemosynthetic polypeptide drugs are considered closely important mainly b…